Leaders with Vanderbilt University Medical Center announced plans today for construction of the largest expansion to date for Vanderbilt University Hospital (VUH). Through this project a new inpatient tower will be built atop an existing parking structure located between 21st Avenue South and Medical Center Drive.
Vanderbilt University Medical Center and Roivant Social Ventures (RSV) this week announced an intention to collaborate in developing therapies for traditionally underserved populations and diseases. RSV is a not-for-profit social impact organization founded by executives from Roivant Sciences that is focused on improving health equity.
The study, published in the journal Nature Human Behaviour, is the first large-scale genome-wide association study of a musical trait. Gordon and Lea Davis, PhD, associate professor of Medicine, both co-senior authors on the findings, along with Maria Niarchou, PhD, research instructor in the Department of Medicine and first author of the paper, co-led a team of international collaborators in novel groundwork toward understanding the biology underlying how musicality relates to other health traits.
Kelly Dooley, MD, PhD, MPH, has been appointed professor and Addison B. Scoville Jr. Chair in Medicine and director of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center, effective Sept. 12. Dooley comes to Vanderbilt from The Johns Hopkins School of Medicine in Baltimore, Maryland, where she is professor of Medicine, and Pharmacology and Molecular Sciences.
A $10 million gift from the Brock family, including John F. Brock III, his wife, Mary, and their three adult children – Rebecca Brock Dixon, John F. Brock IV and Major Brock – will establish the Brock Family Center for Applied Innovation at Vanderbilt University Medical Center.
Emergency Medicine and Trauma Surgery researchers at Vanderbilt University Medical Center (VUMC) are joining Vanderbilt LifeFlight in a Department of Defense (DOD)-funded clinical trial aimed at improving survival with resuscitation techniques used to keep patients alive after a traumatic injury.
A new observational study from Vanderbilt University Medical Center points to solutions for efficient clinical prediction of suicide attempt or suicidal thinking in adults. Reported May 13 in JAMA Open by Drew Wilimitis, Colin Walsh, MD, MA, and colleagues, the study compares an artificial intelligence algorithm with face-to-face screening.
Recommendations for academic health centers in addressing a challenging economic outlook are set out in a new report issued by the Blue Ridge Academic Health Group (BRAHG).
Ruth Lehmann, PhD, director of the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, and a world-renowned developmental geneticist, is the recipient of the 2022 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center announced this week.
A study comparing 618 military veterans who deployed to a combat zone after Sept. 11, 2001, and 2,099 health care workers (HCWs) working during the COVID-19 pandemic found similar levels of potential moral injury (PMI), with 46.1% of veterans and 50.7% of HCWs reporting PMI.
In a new study from Vanderbilt University Medical Center, 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.
Earlier this month the All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.
Critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation (ECMO) lived more often when randomized to receive baricitinib. Doctors call this drug ‘bari,’ and receiving the pill once a day for up to 14 days yielded one of the largest a survival advantages seen yet in the COVID pandemic, according to a study published in The Lancet Respiratory Medicine.
Five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized, according to a study published in JAMA Pediatrics.
On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.
Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.
The combination of two monoclonal antibodies, called Evusheld, was authorized as a pre-exposure prophylaxis to prevent COVID-19 in adults and children 12 years and older who have compromised immune systems or a history of severe adverse reactions to a COVID-19 vaccine.
Vanderbilt Kennedy Center (VKC) researchers, as part of the Centers for Disease Control and Prevention (CDC) Autism and Developmental Disabilities Monitoring (ADDM) network, report an increase in the number of children in Tennessee with autism spectrum disorder (ASD).
The Vanderbilt Undiagnosed Diseases Program (VUDP), which accepts patients with undiagnosed and rare diseases, will be part of a unique network of institutions dedicated to the outstanding treatment of rare disease patients and collaboration to improve standards of care, advance research and increase awareness about rare diseases in the broader medical and patient communities.
The leading cause of HCV in the U.S. is injection drug use as a result of opioid use disorder (OUD), which has seen a rise in most populations, including pregnant people, in recent years. HCV rates have also risen. Between 2009 and 2019, the overall rate per 1,000 live births of HCV in pregnant people increased from 1.8 to 5.1.
Monroe Carell Jr. Children’s Hospital at Vanderbilt typically sees a case of functional tics every few months, according to Heather Riordan, MD, associate professor of Child Neurology. Now the team is seeing a few new cases a week.
The long-acting antibody combination was originally developed at Vanderbilt University Medical Center to protect against COVID-19.
The drug, known as molnupiravir, was first shown to be efficacious against coronaviruses including the COVID-19 virus, SARS-CoV-2, by investigators in the lab of Mark Denison, MD, at Vanderbilt University Medical Center, and their colleagues at the University of North Carolina at Chapel Hill.
Vanderbilt University Medical Center has been awarded a five-year, $31.7 million grant by the National Institute on Aging, part of the National Institutes of Health (NIH), to harmonize research data gathered on human subjects in scores of disparate studies of Alzheimer’s disease and related dementias (ADRD).
A new 4,600-square-foot, state-of-the-art maternal fetal clinic space located at Monroe Carell Jr. Children’s Hospital at Vanderbilt opened Sept. 13 to allow these specialists to further enhance and grow innovative programming that helps families seek optimal outcomes for their unborn babies.
President Joe Biden has appointed Karen Winkfield, MD, PhD, to the National Cancer Advisory Board, where she will serve a six-year term and help guide federal initiatives that focus on cancer.
The study, “Factors Associated with COVID-19 Disease Severity in U.S. Children,” published in the Journal of Hospital Medicine, determined the factors associated with severe disease and poor health outcomes among children presenting to the hospital with COVID. These included older age and chronic co-morbidities such as obesity, diabetes and neurologic conditions, among others.
Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.
Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).
A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults later exposed to the virus by 77%, the company announced today.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right